Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03614728 |
| Title | Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35294-3300 | United States | Details | |
| GSK Investigational Site | Miami | Florida | 33136 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02114 | United States | Details | |
| GSK Investigational Site | Boston | Massachusetts | 02215 | United States | Details | |
| GSK Investigational Site | New York | New York | 10065 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details | |
| GSK Investigational Site | Milwaukee | Wisconsin | 53226 | United States | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details |